• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Prescription Drug Benefit Primer

by Pamela Kumar, RN • April 1, 2006

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

As of January 1, 2006, all prescription drug coverage for those enrolled in both Medicare and Medicaid (dually eligible individuals) is provided through Medicare Part D. Beneficiaries enrolled in Medicaid who had not selected a prescription drug plan by that date were randomly assigned a Part D plan so that they would not miss coverage. Prescription drug coverage for these beneficiaries has no premiums, no deductibles, and little or no prescription co-pays, depending upon the beneficiary’s income.

You Might Also Like

  • When It Comes to Drug Development, What Do Our Dollars Buy?
  • A Look at National Health Spending
  • New Medicaid Changes in West Virginia and Kentucky May Affect Otolaryngology Practice
  • Drug Marketing: Different Impacts on Different Physicians
Explore This Issue
April 2006

Who Stands to Benefit Most from Part D?

Beneficiaries with high prescription drugs costs will receive the greatest benefit from Medicare Part D; after enrollees have paid $3,600 out-of-pocket, prescription drug plans will cover 95% of any additional costs during the year, providing significant financial relief to beneficiaries with high drug bills.

Of course, beneficiaries who have current drug coverage through Medigap plans that supplement Medicare coverage will also benefit by joining a Part D plan since most Medigap coverage is not as good as that of Medicare Part D. Patients may keep the Medigap policies that they have now, including the prescription drug coverage, or they may keep the current Medigap policies but replace the current prescription drug coverage with the Medicare prescription drug plan. They may also enroll in a Medicare Advantage Plan that includes prescription drug coverage.

Beneficiaries who are able to find a prescription drug plan that covers all or most of their prescription drugs will benefit more than those who are unable to do so. Patients whose prescription drugs are not covered by their plan may change to a different drug, pay for it out of pocket, or stop taking the drug, which may adversely affect their health. The Medicare Rx Drug Plan Finder at www.medicare.gov is a tool to help patients select a plan based on cost, convenience, and the medicines they take. CMS has also created a Web-based formulary finder: http://formularyfinder.medicare.gov/formularyfinder/selectstate.asp which provides a list of all Part D plans in a given state and links directly to a plan’s home page for a complete formulary.

Finally, beneficiaries with employer-sponsored retiree health benefits should not switch to a Medicare plan unless they are told by the employer that their current coverage is not as good as the Medicare drug coverage. In fact, several companies whose prescription drug coverage is more generous than standard Medicare prescription drug coverage are telling retirees that if they cancel their prescription drug coverage to enroll in the new Medicare drug benefit, they will lose all employer-sponsored health benefits.

Glitches in Launching the Medicare Drug Plan

Some beneficiaries who enrolled in a Part D plan by December 31, 2005, had not received their Medicare drug-plan cards before their next trip to the pharmacy, and the national computerized system for verifying benefits had some difficulty in processing requests for many seniors who believed that they should be covered. In some cases, pharmacies issued free two- and three-day supplies of medications to carry over customers who didn’t have proof that they were covered. However, some beneficiaries have had to pay out-of-pocket due to problems with their cards and others have had to go back to their doctors to get some free samples to carry them over until their cards are processed.

Pages: 1 2 3 4 | Single Page

Filed Under: Departments, Health Policy, Medical Education, Practice Management Tagged With: healthcare reform, insurance, Medicare, medication, pharmaceuticals, policy, reimbursementIssue: April 2006

You Might Also Like:

  • When It Comes to Drug Development, What Do Our Dollars Buy?
  • A Look at National Health Spending
  • New Medicaid Changes in West Virginia and Kentucky May Affect Otolaryngology Practice
  • Drug Marketing: Different Impacts on Different Physicians

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939